Inventor · disambiguated record
Abhay Kulkarni
Also filed as: KULKARNI ABHAY
11 granted patents·6 pending applications·23 citations·filing 2012–2025
84Inventor score
Files withGLENMARK SPECIALTY SA9GLENMARK PHARMACEUTICALS SA4GLENMARK PHARMACEUTICALS LTD2KHAIRATAKAR-JOSHI NEELIMA1KHAIRATKAR-JOSHI NEELIMA1
Top patents by PatentIndex Score
17 records- 0191US12303635B2Dispensing device and pharmaceutical composition for the treatment of rhinitisGLENMARK SPECIALTY SA·Filed 2023·Granted May 20, 2025·1 cites·10 claims
- 0287US9855229B2Treatment of respiratory disorders using ROR-gamma inhibitorsGLENMARK PHARMACEUTICALS SA·Filed 2016·Granted Jan 2, 2018·12 cites·5 claims
- 0382US10016443B2Treatment of allergic rhinitis using a combination of mometasone and olopatadineGLENMARK SPECIALTY SA·Filed 2017·Granted Jul 10, 2018·2 cites·24 claims
- 0481US2024156840A1Treatment of allergic rhinitis using a combination of mometasone and olopatadineGLENMARK SPECIALTY SA·Filed 2023·Application pending·0 cites
- 0578US12064442B2Treatment of allergic rhinitis using a combination of mometasone and olopatadineGLENMARK SPECIALTY SA·Filed 2022·Granted Aug 20, 2024·0 cites·18 claims
- 0675US9186360B2Treatment of respiratory disorders using TRPA1 antagonistsKHAIRATKAR-JOSHI NEELIMA·Filed 2012·Granted Nov 17, 2015·6 cites·7 claims
- 0771US10548907B2Treatment of allergic rhinitis using a combination of mometasone and olopatadineGLENMARK PHARMACEUTICALS LTD·Filed 2015·Granted Feb 4, 2020·1 cites·32 claims
- 0870US11400101B2Treatment of allergic rhinitis using a combination of mometasone and olopatadineGLENMARK SPECIALTY SA·Filed 2020·Granted Aug 2, 2022·0 cites·26 claims
- 0967US11679210B2Dispensing device and pharmaceutical composition for the treatment of rhinitisGLENMARK SPECIALTY SA·Filed 2018·Granted Jun 20, 2023·1 cites·16 claims
- 1064US2025242115A1Dispensing device and pharmaceutical composition for the treatment of rhinitisGLENMARK SPECIALTY SA·Filed 2025·Application pending·0 cites
- 1158US10758550B2Treatment of allergic rhinitis using a combination of mometasone and olopatadineGLENMARK SPECIALTY SA·Filed 2018·Granted Sep 1, 2020·0 cites·32 claims
- 1255US10646500B2Treatment of allergic rhinitis using a combination of mometasone and olopatadineGLENMARK PHARMACEUTICALS LTD·Filed 2014·Granted May 12, 2020·0 cites·15 claims
- 1350US10653661B2Treatment of allergic rhinitis using a combination of mometasone and olopatadineGLENMARK SPECIALTY SA·Filed 2017·Granted May 19, 2020·0 cites·5 claims
- 1446US2014107113A1Pharmaceutical composition comprising a trpa1 antagonist and a beta-2 agonistGLENMARK PHARMACEUTICALS SA·Filed 2012·Application pending·0 cites
- 1545US2014148423A1Pharmaceutical composition comprising a trpa1 antagonist and a steroidKHAIRATAKAR-JOSHI NEELIMA·Filed 2012·Application pending·0 cites
- 1642US2016158236A1Pharmaceutical composition comprising a trpa1 antagonist and a steroidGLENMARK PHARMACEUTICALS SA·Filed 2015·Application pending·0 cites
- 1741US2014364445A1Pharmaceutical composition comprising a trpa1 antagonist and an anticholinergic agentGLENMARK PHARMACEUTICALS SA·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Abhay Kulkarni files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →